Global Nanobiotechnology Market Insights, Forecast to 2031

Report ID: 1666895 | Published Date: Feb 2026 | No. of Page: 128 | Base Year: 2025 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Nanomedicine
        1.2.3 Nano Medical Devices
        1.2.4 Nano Diagnosis
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Nanobiotechnology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anticancer
        1.3.3 CNS Product
        1.3.4 Anti-infective
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Nanobiotechnology Market Perspective (2017-2028)
    2.2 Nanobiotechnology Growth Trends by Region
        2.2.1 Nanobiotechnology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Nanobiotechnology Historic Market Size by Region (2017-2022)
        2.2.3 Nanobiotechnology Forecasted Market Size by Region (2023-2028)
    2.3 Nanobiotechnology Market Dynamics
        2.3.1 Nanobiotechnology Industry Trends
        2.3.2 Nanobiotechnology Market Drivers
        2.3.3 Nanobiotechnology Market Challenges
        2.3.4 Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Nanobiotechnology Players by Revenue
        3.1.1 Global Top Nanobiotechnology Players by Revenue (2017-2022)
        3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2017-2022)
    3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Nanobiotechnology Revenue
    3.4 Global Nanobiotechnology Market Concentration Ratio
        3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2021
    3.5 Nanobiotechnology Key Players Head office and Area Served
    3.6 Key Players Nanobiotechnology Product Solution and Service
    3.7 Date of Enter into Nanobiotechnology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobiotechnology Breakdown Data by Type
    4.1 Global Nanobiotechnology Historic Market Size by Type (2017-2022)
    4.2 Global Nanobiotechnology Forecasted Market Size by Type (2023-2028)
5 Nanobiotechnology Breakdown Data by Application
    5.1 Global Nanobiotechnology Historic Market Size by Application (2017-2022)
    5.2 Global Nanobiotechnology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Nanobiotechnology Market Size (2017-2028)
    6.2 North America Nanobiotechnology Market Size by Type
        6.2.1 North America Nanobiotechnology Market Size by Type (2017-2022)
        6.2.2 North America Nanobiotechnology Market Size by Type (2023-2028)
        6.2.3 North America Nanobiotechnology Market Share by Type (2017-2028)
    6.3 North America Nanobiotechnology Market Size by Application
        6.3.1 North America Nanobiotechnology Market Size by Application (2017-2022)
        6.3.2 North America Nanobiotechnology Market Size by Application (2023-2028)
        6.3.3 North America Nanobiotechnology Market Share by Application (2017-2028)
    6.4 North America Nanobiotechnology Market Size by Country
        6.4.1 North America Nanobiotechnology Market Size by Country (2017-2022)
        6.4.2 North America Nanobiotechnology Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Nanobiotechnology Market Size (2017-2028)
    7.2 Europe Nanobiotechnology Market Size by Type
        7.2.1 Europe Nanobiotechnology Market Size by Type (2017-2022)
        7.2.2 Europe Nanobiotechnology Market Size by Type (2023-2028)
        7.2.3 Europe Nanobiotechnology Market Share by Type (2017-2028)
    7.3 Europe Nanobiotechnology Market Size by Application
        7.3.1 Europe Nanobiotechnology Market Size by Application (2017-2022)
        7.3.2 Europe Nanobiotechnology Market Size by Application (2023-2028)
        7.3.3 Europe Nanobiotechnology Market Share by Application (2017-2028)
    7.4 Europe Nanobiotechnology Market Size by Country
        7.4.1 Europe Nanobiotechnology Market Size by Country (2017-2022)
        7.4.2 Europe Nanobiotechnology Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Nanobiotechnology Market Size (2017-2028)
    8.2 Asia-Pacific Nanobiotechnology Market Size by Type
        8.2.1 Asia-Pacific Nanobiotechnology Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Nanobiotechnology Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Nanobiotechnology Market Share by Type (2017-2028)
    8.3 Asia-Pacific Nanobiotechnology Market Size by Application
        8.3.1 Asia-Pacific Nanobiotechnology Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Nanobiotechnology Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Nanobiotechnology Market Share by Application (2017-2028)
    8.4 Asia-Pacific Nanobiotechnology Market Size by Region
        8.4.1 Asia-Pacific Nanobiotechnology Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Nanobiotechnology Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Nanobiotechnology Market Size (2017-2028)
    9.2 Latin America Nanobiotechnology Market Size by Type
        9.2.1 Latin America Nanobiotechnology Market Size by Type (2017-2022)
        9.2.2 Latin America Nanobiotechnology Market Size by Type (2023-2028)
        9.2.3 Latin America Nanobiotechnology Market Share by Type (2017-2028)
    9.3 Latin America Nanobiotechnology Market Size by Application
        9.3.1 Latin America Nanobiotechnology Market Size by Application (2017-2022)
        9.3.2 Latin America Nanobiotechnology Market Size by Application (2023-2028)
        9.3.3 Latin America Nanobiotechnology Market Share by Application (2017-2028)
    9.4 Latin America Nanobiotechnology Market Size by Country
        9.4.1 Latin America Nanobiotechnology Market Size by Country (2017-2022)
        9.4.2 Latin America Nanobiotechnology Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Nanobiotechnology Market Size (2017-2028)
    10.2 Middle East & Africa Nanobiotechnology Market Size by Type
        10.2.1 Middle East & Africa Nanobiotechnology Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Nanobiotechnology Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Nanobiotechnology Market Share by Type (2017-2028)
    10.3 Middle East & Africa Nanobiotechnology Market Size by Application
        10.3.1 Middle East & Africa Nanobiotechnology Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Nanobiotechnology Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Nanobiotechnology Market Share by Application (2017-2028)
    10.4 Middle East & Africa Nanobiotechnology Market Size by Country
        10.4.1 Middle East & Africa Nanobiotechnology Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Nanobiotechnology Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Nanobiotechnology Introduction
        11.1.4 Amgen Revenue in Nanobiotechnology Business (2017-2022)
        11.1.5 Amgen Recent Developments
    11.2 Teva Pharmaceuticals
        11.2.1 Teva Pharmaceuticals Company Details
        11.2.2 Teva Pharmaceuticals Business Overview
        11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction
        11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022)
        11.2.5 Teva Pharmaceuticals Recent Developments
    11.3 Abbott
        11.3.1 Abbott Company Details
        11.3.2 Abbott Business Overview
        11.3.3 Abbott Nanobiotechnology Introduction
        11.3.4 Abbott Revenue in Nanobiotechnology Business (2017-2022)
        11.3.5 Abbott Recent Developments
    11.4 UCB
        11.4.1 UCB Company Details
        11.4.2 UCB Business Overview
        11.4.3 UCB Nanobiotechnology Introduction
        11.4.4 UCB Revenue in Nanobiotechnology Business (2017-2022)
        11.4.5 UCB Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Nanobiotechnology Introduction
        11.5.4 Roche Revenue in Nanobiotechnology Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 Celgene
        11.6.1 Celgene Company Details
        11.6.2 Celgene Business Overview
        11.6.3 Celgene Nanobiotechnology Introduction
        11.6.4 Celgene Revenue in Nanobiotechnology Business (2017-2022)
        11.6.5 Celgene Recent Developments
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Nanobiotechnology Introduction
        11.7.4 Sanofi Revenue in Nanobiotechnology Business (2017-2022)
        11.7.5 Sanofi Recent Developments
    11.8 Merck & Co
        11.8.1 Merck & Co Company Details
        11.8.2 Merck & Co Business Overview
        11.8.3 Merck & Co Nanobiotechnology Introduction
        11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2017-2022)
        11.8.5 Merck & Co Recent Developments
    11.9 Biogen
        11.9.1 Biogen Company Details
        11.9.2 Biogen Business Overview
        11.9.3 Biogen Nanobiotechnology Introduction
        11.9.4 Biogen Revenue in Nanobiotechnology Business (2017-2022)
        11.9.5 Biogen Recent Developments
    11.10 Stryker
        11.10.1 Stryker Company Details
        11.10.2 Stryker Business Overview
        11.10.3 Stryker Nanobiotechnology Introduction
        11.10.4 Stryker Revenue in Nanobiotechnology Business (2017-2022)
        11.10.5 Stryker Recent Developments
    11.11 Gilead Sciences
        11.11.1 Gilead Sciences Company Details
        11.11.2 Gilead Sciences Business Overview
        11.11.3 Gilead Sciences Nanobiotechnology Introduction
        11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022)
        11.11.5 Gilead Sciences Recent Developments
    11.12 Pfizer
        11.12.1 Pfizer Company Details
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Nanobiotechnology Introduction
        11.12.4 Pfizer Revenue in Nanobiotechnology Business (2017-2022)
        11.12.5 Pfizer Recent Developments
    11.13 3M Company
        11.13.1 3M Company Company Details
        11.13.2 3M Company Business Overview
        11.13.3 3M Company Nanobiotechnology Introduction
        11.13.4 3M Company Revenue in Nanobiotechnology Business (2017-2022)
        11.13.5 3M Company Recent Developments
    11.14 Johnson & Johnson
        11.14.1 Johnson & Johnson Company Details
        11.14.2 Johnson & Johnson Business Overview
        11.14.3 Johnson & Johnson Nanobiotechnology Introduction
        11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022)
        11.14.5 Johnson & Johnson Recent Developments
    11.15 Smith & Nephew
        11.15.1 Smith & Nephew Company Details
        11.15.2 Smith & Nephew Business Overview
        11.15.3 Smith & Nephew Nanobiotechnology Introduction
        11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022)
        11.15.5 Smith & Nephew Recent Developments
    11.16 Leadiant Biosciences
        11.16.1 Leadiant Biosciences Company Details
        11.16.2 Leadiant Biosciences Business Overview
        11.16.3 Leadiant Biosciences Nanobiotechnology Introduction
        11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022)
        11.16.5 Leadiant Biosciences Recent Developments
    11.17 Kyowa Hakko Kirin
        11.17.1 Kyowa Hakko Kirin Company Details
        11.17.2 Kyowa Hakko Kirin Business Overview
        11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction
        11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022)
        11.17.5 Kyowa Hakko Kirin Recent Developments
    11.18 Shire
        11.18.1 Shire Company Details
        11.18.2 Shire Business Overview
        11.18.3 Shire Nanobiotechnology Introduction
        11.18.4 Shire Revenue in Nanobiotechnology Business (2017-2022)
        11.18.5 Shire Recent Developments
    11.19 Ipsen
        11.19.1 Ipsen Company Details
        11.19.2 Ipsen Business Overview
        11.19.3 Ipsen Nanobiotechnology Introduction
        11.19.4 Ipsen Revenue in Nanobiotechnology Business (2017-2022)
        11.19.5 Ipsen Recent Developments
    11.20 Endo International
        11.20.1 Endo International Company Details
        11.20.2 Endo International Business Overview
        11.20.3 Endo International Nanobiotechnology Introduction
        11.20.4 Endo International Revenue in Nanobiotechnology Business (2017-2022)
        11.20.5 Endo International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Nanomedicine
    Table 3. Key Players of Nano Medical Devices
    Table 4. Key Players of Nano Diagnosis
    Table 5. Key Players of Other
    Table 6. Global Nanobiotechnology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Nanobiotechnology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Nanobiotechnology Market Share by Region (2017-2022)
    Table 10. Global Nanobiotechnology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Nanobiotechnology Market Share by Region (2023-2028)
    Table 12. Nanobiotechnology Market Trends
    Table 13. Nanobiotechnology Market Drivers
    Table 14. Nanobiotechnology Market Challenges
    Table 15. Nanobiotechnology Market Restraints
    Table 16. Global Nanobiotechnology Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Nanobiotechnology Revenue Share by Players (2017-2022)
    Table 18. Global Top Nanobiotechnology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021)
    Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Nanobiotechnology Product Solution and Service
    Table 23. Date of Enter into Nanobiotechnology Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Nanobiotechnology Revenue Market Share by Type (2017-2022)
    Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Nanobiotechnology Revenue Market Share by Type (2023-2028)
    Table 29. Global Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Nanobiotechnology Revenue Share by Application (2017-2022)
    Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Nanobiotechnology Revenue Share by Application (2023-2028)
    Table 33. North America Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Nanobiotechnology Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Nanobiotechnology Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Nanobiotechnology Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Nanobiotechnology Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Nanobiotechnology Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Nanobiotechnology Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Nanobiotechnology Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Nanobiotechnology Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Nanobiotechnology Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Nanobiotechnology Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Nanobiotechnology Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Amgen Company Details
    Table 64. Amgen Business Overview
    Table 65. Amgen Nanobiotechnology Product
    Table 66. Amgen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 67. Amgen Recent Developments
    Table 68. Teva Pharmaceuticals Company Details
    Table 69. Teva Pharmaceuticals Business Overview
    Table 70. Teva Pharmaceuticals Nanobiotechnology Product
    Table 71. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 72. Teva Pharmaceuticals Recent Developments
    Table 73. Abbott Company Details
    Table 74. Abbott Business Overview
    Table 75. Abbott Nanobiotechnology Product
    Table 76. Abbott Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 77. Abbott Recent Developments
    Table 78. UCB Company Details
    Table 79. UCB Business Overview
    Table 80. UCB Nanobiotechnology Product
    Table 81. UCB Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 82. UCB Recent Developments
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Nanobiotechnology Product
    Table 86. Roche Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 87. Roche Recent Developments
    Table 88. Celgene Company Details
    Table 89. Celgene Business Overview
    Table 90. Celgene Nanobiotechnology Product
    Table 91. Celgene Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 92. Celgene Recent Developments
    Table 93. Sanofi Company Details
    Table 94. Sanofi Business Overview
    Table 95. Sanofi Nanobiotechnology Product
    Table 96. Sanofi Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 97. Sanofi Recent Developments
    Table 98. Merck & Co Company Details
    Table 99. Merck & Co Business Overview
    Table 100. Merck & Co Nanobiotechnology Product
    Table 101. Merck & Co Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 102. Merck & Co Recent Developments
    Table 103. Biogen Company Details
    Table 104. Biogen Business Overview
    Table 105. Biogen Nanobiotechnology Product
    Table 106. Biogen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 107. Biogen Recent Developments
    Table 108. Stryker Company Details
    Table 109. Stryker Business Overview
    Table 110. Stryker Nanobiotechnology Product
    Table 111. Stryker Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 112. Stryker Recent Developments
    Table 113. Gilead Sciences Company Details
    Table 114. Gilead Sciences Business Overview
    Table 115. Gilead Sciences Nanobiotechnology Product
    Table 116. Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 117. Gilead Sciences Recent Developments
    Table 118. Pfizer Company Details
    Table 119. Pfizer Business Overview
    Table 120. Pfizer Nanobiotechnology Product
    Table 121. Pfizer Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 122. Pfizer Recent Developments
    Table 123. 3M Company Company Details
    Table 124. 3M Company Business Overview
    Table 125. 3M Company Nanobiotechnology Product
    Table 126. 3M Company Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 127. 3M Company Recent Developments
    Table 128. Johnson & Johnson Company Details
    Table 129. Johnson & Johnson Business Overview
    Table 130. Johnson & Johnson Nanobiotechnology Product
    Table 131. Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 132. Johnson & Johnson Recent Developments
    Table 133. Smith & Nephew Company Details
    Table 134. Smith & Nephew Business Overview
    Table 135. Smith & Nephew Nanobiotechnology Product
    Table 136. Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 137. Smith & Nephew Recent Developments
    Table 138. Leadiant Biosciences Company Details
    Table 139. Leadiant Biosciences Business Overview
    Table 140. Leadiant Biosciences Nanobiotechnology Product
    Table 141. Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 142. Leadiant Biosciences Recent Developments
    Table 143. Kyowa Hakko Kirin Company Details
    Table 144. Kyowa Hakko Kirin Business Overview
    Table 145. Kyowa Hakko Kirin Nanobiotechnology Product
    Table 146. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 147. Kyowa Hakko Kirin Recent Developments
    Table 148. Shire Company Details
    Table 149. Shire Business Overview
    Table 150. Shire Nanobiotechnology Product
    Table 151. Shire Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 152. Shire Recent Developments
    Table 153. Ipsen Company Details
    Table 154. Ipsen Business Overview
    Table 155. Ipsen Nanobiotechnology Product
    Table 156. Ipsen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 157. Ipsen Recent Developments
    Table 158. Endo International Company Details
    Table 159. Endo International Business Overview
    Table 160. Endo International Nanobiotechnology Product
    Table 161. Endo International Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 162. Endo International Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanobiotechnology Market Share by Type: 2021 VS 2028
    Figure 2. Nanomedicine Features
    Figure 3. Nano Medical Devices Features
    Figure 4. Nano Diagnosis Features
    Figure 5. Other Features
    Figure 6. Global Nanobiotechnology Market Share by Application: 2021 VS 2028
    Figure 7. Anticancer Case Studies
    Figure 8. CNS Product Case Studies
    Figure 9. Anti-infective Case Studies
    Figure 10. Other Case Studies
    Figure 11. Nanobiotechnology Report Years Considered
    Figure 12. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Nanobiotechnology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nanobiotechnology Market Share by Region: 2021 VS 2028
    Figure 15. Global Nanobiotechnology Market Share by Players in 2021
    Figure 16. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2021
    Figure 18. North America Nanobiotechnology Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Nanobiotechnology Market Size Market Share by Type (2017-2028)
    Figure 20. North America Nanobiotechnology Market Size Market Share by Application (2017-2028)
    Figure 21. North America Nanobiotechnology Market Size Share by Country (2017-2028)
    Figure 22. United States Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Nanobiotechnology Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Nanobiotechnology Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Nanobiotechnology Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Nanobiotechnology Market Size Share by Country (2017-2028)
    Figure 28. Germany Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Nanobiotechnology Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Nanobiotechnology Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Nanobiotechnology Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Nanobiotechnology Market Size Share by Region (2017-2028)
    Figure 38. China Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Nanobiotechnology Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Nanobiotechnology Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Nanobiotechnology Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Nanobiotechnology Market Size Share by Country (2017-2028)
    Figure 48. Mexico Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Nanobiotechnology Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Nanobiotechnology Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Nanobiotechnology Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Nanobiotechnology Market Size Share by Country (2017-2028)
    Figure 54. Turkey Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Amgen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 58. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 59. Abbott Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 60. UCB Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 61. Roche Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 62. Celgene Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 63. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 64. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 65. Biogen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 66. Stryker Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 67. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 68. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 69. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 70. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 71. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 72. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 73. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 74. Shire Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 75. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 76. Endo International Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Frequently Asked Questions
Nanobiotechnology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nanobiotechnology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nanobiotechnology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nanofibers

Nanofibers market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More